SYN-Tech Chem & Pharm Co Ltd - Asset Resilience Ratio

Latest as of June 2023: 0.42%

SYN-Tech Chem & Pharm Co Ltd (1777) has an Asset Resilience Ratio of 0.42% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SYN-Tech Chem & Pharm Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

NT$12.09 Million

≈ $380.78K USD Cash + Short-term Investments

Total Assets

NT$2.90 Billion

≈ $91.48 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2022)

This chart shows how SYN-Tech Chem & Pharm Co Ltd's Asset Resilience Ratio has changed over time. See SYN-Tech Chem & Pharm Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down SYN-Tech Chem & Pharm Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 1777 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$12.09 Million	0.42%
Total Liquid Assets	NT$12.09 Million	0.42%

Asset Resilience Insights

Limited Liquidity: SYN-Tech Chem & Pharm Co Ltd maintains only 0.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SYN-Tech Chem & Pharm Co Ltd Industry Peers by Asset Resilience Ratio

Compare SYN-Tech Chem & Pharm Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for SYN-Tech Chem & Pharm Co Ltd (2015–2022)

The table below shows the annual Asset Resilience Ratio data for SYN-Tech Chem & Pharm Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	4.29%	NT$119.16 Million ≈ $3.75 Million	NT$2.78 Billion ≈ $87.57 Million	-4.66pp
2021-12-31	8.95%	NT$259.09 Million ≈ $8.16 Million	NT$2.90 Billion ≈ $91.21 Million	+0.64pp
2019-12-31	8.31%	NT$154.60 Million ≈ $4.87 Million	NT$1.86 Billion ≈ $58.63 Million	-6.69pp
2018-12-31	15.00%	NT$273.63 Million ≈ $8.62 Million	NT$1.82 Billion ≈ $57.49 Million	-5.77pp
2017-12-31	20.77%	NT$323.16 Million ≈ $10.18 Million	NT$1.56 Billion ≈ $49.02 Million	+20.56pp
2016-12-31	0.21%	NT$2.73 Million ≈ $85.85K	NT$1.29 Billion ≈ $40.56 Million	-4.53pp
2015-12-31	4.74%	NT$58.00 Million ≈ $1.83 Million	NT$1.22 Billion ≈ $38.57 Million	--

pp = percentage points

About SYN-Tech Chem & Pharm Co Ltd

TWO:1777 Taiwan Biotechnology

Market Cap

$99.61 Million

NT$3.16 Billion TWD

Market Cap Rank

#19197 Global

#1082 in Taiwan

Share Price

NT$70.90

Change (1 day)

+0.00%

52-Week Range

NT$70.30 - NT$91.50

All Time High

NT$108.00